Ignite Creation Date:
2025-12-24 @ 4:20 PM
Ignite Modification Date:
2026-05-13 @ 8:50 PM
Study NCT ID:
NCT04556266
Status:
WITHDRAWN
Last Update Posted:
2025-05-13
First Post:
2020-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
17-331
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None